Abstract microRNAs (miRNA) are well suited to the task of regulating gene expression networks, because any given miRNA has the capacity to target dozens, if not hundreds, of genes. The simultaneous targeting of multiple genes within a pathway may enable miRNAs to more strongly regulate the pathway, or to achieve more subtle control through the targeting of distinct subnetworks of genes. Therefore, as our capacity to discover miRNA targets en masse increases, so must our consideration of the complex networks in which these genes participate. We highlight recent studies in which the comprehensive identification of targets has been used to elucidate miRNA-regulated gene networks in cancer, focusing especially upon miRNAs such as members of the miR-200 family that regulate epithelial-mesenchymal transition (EMT), a reversible phenotypic switch whereby epithelial cells take on the more invasive properties of their mesenchymal counterparts. These studies have expanded our understanding of the roles of miRNAs in EMT, which were already known to form important regulatory loops with key transcription factors to regulate the epithelial or mesenchymal properties of cells. Cancer Res; 75(13); 2594-9. Ó2015 AACR.
Introduction
The advent of genomic and proteomic technologies has brought with it an enhanced appreciation of the intricacies and extensiveness of regulatory networks that control the internal workings of cells. ChIP-seq methods have revealed that individual transcription factors and chromatin modifiers may each bind at thousands of sites in the genome, while RNA-seq in various modes has extended our appreciation of posttranscriptional regulation. The participation of genes within biologic networks, and the development of technologies capable of simultaneously measuring gene expression on a transcriptome-wide scale, has led to the emergence of network modeling as a means to understand biologic function. The integration of genes into networks increases both the subtlety and the robustness of biologic systems, and can mitigate the failure of individual components through redundancy (1) . Within networks, some genes display a high degree of connectivity with their neighbors (termed "hubs"), and it is the removal of these hubs that will have the most impact in fragmenting the network. Hence, network hubs are amenable targets, both for regulation by miRNAs and for drug development. The capacity of individual miRNAs to simultaneously target dozens, if not hundreds, of genes makes miRNAs well suited to participate in regulatory networks and, indeed, computational analysis indicates they are overrepresented in such systems (2, 3) . In theory, the simultaneous regulation of multiple components within a signaling pathway would allow a miRNA the capacity to more effectively regulate a system than would be possible solely through the regulation of any one gene alone. It would also provide the opportunity for more subtle or precise control, potentially regulating specific subnetworks to more finely tune effects. Although biologically important, the complex and cell-specific relationships between the participants in regulatory networks can be difficult to disentangle; consequently, the bulk of publications on regulation by miRNAs investigate one or a few targets. However, approaches to more comprehensively characterize regulatory networks involving miRNAs are emerging. In this review, we describe examples of regulatory networks in which miRNAs participate in controlling epithelial-mesenchymal transition (EMT), an important aspect of cancer, and some of the approaches being used to map these networks. Reviews describing the role of miRNAs on other processes relating to cancer, including the broad regulation of processes such as apoptosis (4), metastasis (5), the cell cycle (6) , and TGFb signaling in cancer (7) , are already covered elsewhere and therefore are not discussed here.
Regulatory Networks in EMT
EMT is characterized by the transformation of epithelial cells, which normally maintain close contacts with their neighbors through tight junctions, adherens junctions, and desmosomes, into a mesenchymal phenotype in which cells dissociate from their neighbors and become motile (8) . Carcinomas, which are the most common form of solid cancers, arise from epithelial cells, and EMT is a crucial step in the progression of these cancers to metastasis. The normal roles of EMT occur early in development to allow gastrulation and neural crest delamination, and later during organ formation. In the adult, EMT occurs during wound healing to facilitate cell migration and tissue repair. EMT involves extensive changes to cell shape and phenotype, notably involving extensive changes in the structure and dynamics of the cytoskeleton, and is underlain by changes in the expression of hundreds of genes. This process is highly coordinated, involving numerous transcription factors that control the expression of the many genes that are upregulated and downregulated during EMT, along with a number of miRNAs that participate in regulating both the EMT-regulating transcription factors and many of the downstream effectors of the EMT.
Transcription factors and miRNAs that regulate EMT: mapping networks one step at a time Dozens of transcription factors have been implicated in controlling EMT, although members of the Snail (SNAI1, SNAI2) and ZEB (ZEB1 and ZEB2) families are especially prominent. Similarly, numerous miRNAs have also been implicated in EMT, with members of the miR-200 family, the miR-34 family, and miR-203 having well-established roles. miRNAs appear to be frequent participants in feedback and feed-forward loops and, indeed, within the context of EMT, extensive regulatory loops have been described between promesenchymal transcription factors (driven by ZEB, SNAIL, Wnt, and Notch family members) and epithelialenforcing miRNAs (of the miR-200, miR-34, and miR-203 families; Fig. 1 ). These operate not only to buffer the effects of noise on gene expression programs but also to function as robust developmental switches, reinforcing genetic programs that drive mutually exclusive states (9) . This is facilitated, not only by miRNAs strongly regulating key genes [such as particularly strong ZEB repression by miR-200 through multiple miRNA-responsive elements within the ZEB1 and ZEB2 3 0 untranslated regions (3 0 UTR)], but also through the capacity of miRNAs to target multiple components of these same signaling pathways. This is exemplified by the suppression of Notch signaling by the miR-200 and miR-34 families, operating through direct repression of signaling ligands (Jag1), receptors/transcription factors (Notch1 and Notch2), and coactivators (Maml2, Maml3). Combinatorial effects of miRNAs are also illustrated by the direct repression of the SNAIL transcription factors by the miR-200, miR-203, and miR-34 families. These network modules, as illustrated in Fig. 1 , have been built up from a number of studies using various cell models that have identified individual regulatory steps. The expression and relative importance of individual transcription factor-miRNA relationships vary between cells, and although these different factors cannot be described as functionally redundant, they nevertheless drive similar processes with a number of these (or similar) regulatory loops likely to operate in any EMT model system.
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(SNAI1 SNAI2) Figure 1 . Key transcription factor-miRNA regulatory loops that underlie EMT. (14) . Similarly, miR-200c inhibits migration, invasion, and cytoskeletal organization independently of ZEB1 and ZEB2, instead suggesting the importance of several actin regulators (15) , while regulation of TUBB3 was deemed central to the ability of miR-200 to increase sensitivity to paclitaxel (16) . To properly understand the functions of miRNAs, such as miR-200, we must therefore undertake a more comprehensive analysis of their targets.
Identification of miRNA Targets on a Transcriptome-wide Scale
In an effort to experimentally identify miRNA targets in a comprehensive and unbiased manner, biochemical approaches involving the immunoprecipitation of RNA-induced silencing complex (RISC) components have been developed. Early efforts identified bound transcripts by microarray or deep sequencing, with the success of this technique borne out in multiple studies in which there was an enrichment of seed sites in coimmunoprecipitated mRNAs over that expected by chance (reviewed in ref. 17 ). However, there were several drawbacks, including the potential for the association of RNA and RNA-binding proteins to occur post-lysis (18) and the failure of these techniques to identify the precise site of targeting. An important methodological advance was the covalent cross-linking of closely juxtaposed RNA and protein by UV irradiation [cross-linked immunoprecipitation (CLIP)-based methodologies]. Although cross-linking efficiency is low, it helps maintain intracellular interactions to enable the use of stringent purification steps to yield high-quality libraries of directly interacting miRNA:mRNA duplexes, and thus diminishes the chance of post-lysis interactions being immunoprecipitated. Furthermore, when coupled with deep sequencing, the use of RNAses to digest non-RISC-protected RNA fragments enables the identification of the sites being targeted. An alternate approach for global identification of targets is to transfect cells with a synthetic biotinylated miRNA, followed by capture of the miRNA with its bound mRNAs using streptavidin. The captured mRNA population, enriched for direct targets, can then be identified by microarray analysis or sequencing. As with CLIPbased procedures, the potential of the technique is demonstrated by the enrichment of seed-target containing transcripts. Success is further demonstrated by the experimental validation of miRNA-regulated pathways that were enriched for targets identified using this technique. This procedure has been used to identify targets of EMT-or invasion-regulating miRNAs, miR-34a (19), miR-139-5p (20) , and miR-522 (21), in each case revealing coordinated targeting of multiple components within regulatory networks. It should be noted that both of these techniques identify physical interactions, but physical interaction alone may not be a good indicator of functionally significant target suppression, especially if the target site pairing is short (6 nucleotides), possess binding site mismatches, or is located in regions other than the 3 0 UTR. However, in our experience with highthroughput sequencing (HITS)-CLIP, and in agreement with earlier work (22) , physical interaction is a robust indicator of function for perfectly paired, longer (7 and 8 nucleotides) seedmatched sites within 3 0 UTRs (23).
The miR-200 Family Regulates a Network of Cytoskeleton Regulators
We used the HITS-CLIP procedure to identify targets of miR200a and miR-200b, representing the two seed-sequence classes within the miR-200 family (23) 
Because regulation of the cytoskeleton is central to EMT, it was not surprising to identify direct cytoskeletal targets of miR-200 family members. However, the identification of dozens of genes within this process was striking in that it implies coordinated and multilayered network regulation. Interestingly, cytoskeletal processes are the most enriched ontology for sites located within 3 0 UTRs (the most productive location for miRNA activity) but not for the less functional sites located within coding regions, where specific processes were not significantly enriched. The capacity of miR-200 to suppress cell movement is well established, but the nature of the targets identified by HITS-CLIP allowed us to characterize multiple specific mechanisms through which miR-200 regulates motility. We found that miR-200 inhibits Rho activation and the downstream processes of MMP production, the formation of invadopodia, and focal adhesion turnover. Importantly, we found these processes are regulated by distinct actin subnetworks subject to inhibition by miR-200. For example, the knockdown of CFL2, MPRIP, WIPF1, and ABL2 all phenocopied miR-200 expression in decreasing 3D wound closure, yet of these four genes, only ABL2 knockdown promoted focal adhesion formation, whereas CFL2, MPRIP, and WIPF1 (but not ABL2) were required for functional invadopodia. This further highlights the utility of miRNAs in network-wide regulation, exerting widespread regulation of various genes or specific pathways within an extended network. Many more genes involved in regulating the cytoskeleton were also found to be targets of miR-200, but their roles in mediating the regulatory effects of miR-200 remain to be analyzed. These include targets that participate in signal transduction pathways (including TGFb and EGFR pathways), components of the Rho-ROCK signaling pathway, and numerous proteins that affect actin and myosin filament assembly and function. How these pathways fit together in the regulatory network modulated by miR-200 remains to be examined in detail.
Further Application of Global Target Identification Methodologies to Identify miRNA-Regulated Processes
HITS-CLIP has also been applied to predict miRNA-regulated networks in other scenarios. Chi and colleagues performed HITS-CLIP in mouse brain tissue and assigned specific miRNAs to specific Ago-HITS-CLIP read clusters ("hotspots" of miRNAbinding) based upon the presence of seed matches for the most abundant endogenous miRNAs (24) . From this analysis, different processes were found to be enriched in the target lists of different miRNAs. For example, miR-124, miR-30, miR-26, let-7, and miR-17 were enriched for neuron development, neuron differentiation, and synaptic transmission. miR-128 and miR-221 were enriched for cation transporters and miR-125 for microtubule-based transport. An alternative approach to target identification uses streptavidin purification of the targets of biotinylated miRNAs and has also been successfully used to identify cancer-associated, miRNA-regulated processes. For example, the identification of targets of primate-specific miR-522 uncovered an overrepresentation of genes associated with proliferation and the cell cycle, migration, and apoptosis (21) . These processes are reminiscent of EMT, which was further implicated by the putative miRNA:transcription factor regulatory loops the authors identified between miR-522 and the known EMT regulators: ELK1, E2F3, PAX3, and TEAD2. The unbiased approach to target identification led to the hypothesis of a novel role for miR-522 in EMT, which was supported by the induction of mesenchymal-like properties upon miR-522 overexpression. EMT-promoting pathways (Wnt, TGFb, and RAS-MAPK signaling) were also enriched after pulldown of biotinylated miR-139-5p, a known tumor suppressor (20) . Successful prediction of the regulation of cancer-associated pathways was also achieved through the network analysis of targets of other biotinylated miRNA pulldowns. Targets of miR-182-5p, previously reported in both tumor-promoting and tumor-suppressing contexts, were enriched in members of the DNA-damage response and downstream G 2 cell-cycle checkpoint, and in breast cancer cells, miR-182-5p was accordingly shown to inhibit homologous recombination (25) . Likewise, the high representation of EGF-RAS-MAPK pathway-associated transcripts in a biotinylated miR34a pulldown suggested that miR-34a may make cells less responsive to EGF signaling, which was experimentally confirmed as ectopic miR-34a decreased basal AKT and ERK phosphorylation and sensitized cells to growth factor withdrawal (19) . In each of these cases, the identification of biologic functions for these miRNAs was made possible by the comprehensive identification and analysis of their target genes.
As a further indication of multicomponent pathway regulation by miRNAs, we have analyzed lists of experimentally validated miRNA target genes from Tarbase (26) for the enrichment of targets within the same biologic pathways (using Reactome, reactome.org; Fig. 2 ). Unlike the unbiased nature of target identification by HITS-CLIP or streptavadin pulldown, the representation of miRNA targets in Tarbase is not necessarily unbiased, and may reflect preferential approaches of the contributing studies, but it does possess the advantage that the targets are all functionally demonstrated. When cross-referenced against the Reactome web tool, pathways highly enriched with targets were identified, suggesting that these pathways are each the subject of coordinated targeting at multiple levels by a miRNA. Indeed, the regulation of many of these pathways by miRNAs has already been reported, such as the regulation of Notch signaling by miR-34 (27) and miR-181 (28), the regulation of nuclear receptors by miR-124 (29) , and the control of senescence by let-7 (30).
Challenges for the Future
The reconstruction of accurate models of gene regulation is appealing in that it promises using the combined power of in silico and experimental biology to understand processes that cannot be practically understood by either method alone. The comprehensive identification and network-based analysis of functional miRNA targets however is not a straightforward endeavor. Merely identifying a physical binding site, particularly when that binding site is not within the target 3 0 UTR or involves weaker seed pairing, does not guarantee a functionally significant interaction, and the influence of the extensive competitive endogenous RNA (ceRNA) networks may be a significant factor confounding interpretation (31, 32) . Experimental confirmation typically requires the manipulation of targets, a goal that is currently achievable for a limited number of key genes but not across an entire pathway in unison. The miRNA-regulatory network is further complicated by the fact that any single miRNA can regulate hundreds of targets, while multiple miRNAs may converge to control the same process. For example, in addition to multilevel regulation of the cytoskeleton by miR-200 that we have described, many other miRNAs (miR-122, miR-142, miR-155, miR-24, miR-23b, let-7, miR-30c, miR-506, and miR-129, to name a few) have also been independently implicated in cytoskeletal regulation. Any of these (or other) miRNAs may work in conjunction to regulate cytoskeletal dynamics and control migration and invasion, and this is but one of many aspects of cell biology that control tumorigenesis.
Although the scale of miRNA-regulated networks is daunting, the development of methods for both high-throughput target identification and of computational methods to integrate this information, means that the thorough mapping of these regulatory networks will likely soon be achieved. The remaining challenges will be to experimentally test these complex network models and to utilize the information to improve the outcomes of therapies to control cancer.
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